EGFR and breast carcinoma: Regarding breast cancer invasiveness, previous studies showed that in ER-negative breast cancer cells or CAFs, E2/GPER signaling induced cell migration through EGFR-dependent activation of connective tissue growth factor (CTGF) [78,79].